From October 26th to 29th, the 18th Malaysian Cardiovascular Intervention Symposium (MyLive2022) was held in Kuala Lumpur Convention Centre, Malaysia. As one of the world's leading international exhibitions in the field of cardiovascular, it has always been one of the greatest platforms for innovative medical device enterprises from China in the field of cardiovascular.

This time, RainMed Medical showed its products in a way of "application, product and solution” at booth D35 in Ballroom 1, Level 3, East Wing, Kuala Lumpur Convention Centre along with global cardiovascular giants Abbott, Medtronic, and Boston Scientific to display forward-looking technologies and treatment plans of innovative medical devices. RainMed demonstrated the application scenarios and cases of caFFR in different environments of many countries around the world, showing international audience and customers its advantages of convenience, accuracy and hyperemic-agent-free as a non-interventional FFR measurement system. RainMed, exhibitors, cardiologists and industry partners from all over the world shared product technology, market application and industry trends with each other to provide more intelligent and cutting-edge solutions for the treatment and prognosis of coronary heart disease.

RainMed staff and Dr. Alan Fong -- President of the National Heart Association of Malaysia

At the exhibition, RainMed demonstrated the preset scene of using caFFR to measure FFR before and after PCI surgery, bringing a new solution for the clinical diagnosis and treatment of coronary heart disease and revealed the significant clinical value of caFFR measurement. It has attracted a large number of visitors, new and old customers who came to learn the product and have in-depth negotiations. In order to show the product innovation results to customers and partners, RainMed team carried out practical product demonstration for visitors to the exhibition, and gave comprehensive and detailed product explanation from a professional point of view.

caFFR calculates fractional flow reserve FFR based on two angiograms without pressure guide wire or hyperemic agents. It can provide functional indicators during surgery to accurately evaluate whether coronary artery stenosis induces myocardial ischemia. It provides a safe, efficient, accurate and simple solution for cardiovascular diagnosis. Designed and produced by a Chinese local team, caFFR will further demonstrate the infinite charm of China’s smart manufacturing on the global stage for hospitals and medical imaging centers at all levels.

RainMed Medical has been deeply engaged in the cardiovascular subdivision field for nearly ten years. Its business focuses on the clinical application and research of coronary fractional flow reserve. It is a solution provider integrating "R&D, production, sales, operation and maintenance". As an international high-tech enterprise, RainMed’s domestic and overseas business models feed back on each other, forming a good closed-loop system.

During the exhibition, RainMed team had a clearer and more comprehensive understanding of customers’ needs through face-to-face in-depth communication, which brought important information for technology research and development and business resumption after the exhibition.

Exhibition Information

Location: D35, Ballroom 1, Level 3, East Wing, Kuala Lumpur Convention Centre

Time: October 27th-29th, 06:30 – 18:00